Venture
eGenesis, Inc.
Latest Form D 2024-02-27- CIK 1682809
- State MA
- Biotechnology
- 5 Form D offerings since 2016-08-23
- Total sold
- $265M
- across 5 offerings
- Rounds
- 5
- Form D offerings since 2016-08-23
- Latest round
- $25.4M
- 2024-02-27 · 021-506139
- Investors
- 11
- on the latest round
Connected
named in its Form D filingsRound timeline
amount sold · by first filed2024-02-27 · $25.4M
- 2016-08-23$2M021-269377
- 2017-03-23$12.6M021-283187
- 2019-11-14$100M021-353437
- 2021-03-10$125M021-391712
- 2024-02-27$25.4M021-506139
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($125M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-506139 | First filed2024-02-27 | Latest2024-02-27 | Sought$28.7M | Sold$25.4M | Investors11 | Exemptions506(b) |
| 021-391712 | First filed2021-03-10 | Latest2021-03-10 | Sought$125M | Sold$125M | Investors43 | Exemptions506(b) |
| 021-353437 | First filed2019-11-14 | Latest2019-11-14 | Sought$100M | Sold$100M | Investors20 | Exemptions506(b) |
| 021-283187 | First filed2017-03-23 | Latest2017-03-23 | Sought$38.2M | Sold$12.6M | Investors12 | Exemptions506(c) |
| 021-269377 | First filed2016-08-23 | Latest2016-08-23 | Sought$3M | Sold$2M | Investors2 | Exemptions506(b) |
Who backs eGenesis, Inc. — 5 inferred investors — and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2024-02-27
| Name | Relationship |
|---|---|
| Paul Sekhri | RelationshipDirector |
| Michael Curtis | RelationshipExecutive Officer, Director |
| Steven Gillis | RelationshipDirector |
| Julie Sunderland | RelationshipDirector |
| Albert Wiegman | RelationshipDirector |
| Lucio Iannone | RelationshipDirector |
| Mark Pruzanski | RelationshipDirector |
| Sarah Schlesinger | RelationshipDirector |
| Kathleen Fanning | RelationshipDirector |
| Rahul Kakkar | RelationshipDirector |
| Brad Smith | RelationshipDirector |
| Jennifer Bergheiser | RelationshipExecutive Officer |
Facts
As its latest Form D states them
- Industry
- Biotechnology
- State
- Massachusetts (MA)
- Exemptions
- Rule 506(b); Rule 506(c)
- First filed
- 2016-08-23
- Latest filing
- 2024-02-27
Who backs eGenesis, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗